Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.

Palimaka S, Blackhouse G, Goeree R.

Ont Health Technol Assess Ser. 2015 Jul 1;15(15):1-43. eCollection 2015.

2.

Modeling Disease Progression with Longitudinal Markers.

Inoue LY, Etzioni R, Morrell C, Müller P.

J Am Stat Assoc. 2008;103(481):259-270.

3.

Review of economic evidence in the prevention and early detection of colorectal cancer.

Jeong KE, Cairns JA.

Health Econ Rev. 2013 Sep 12;3(1):20. doi: 10.1186/2191-1991-3-20.

4.

Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.

Trikalinos TA, Kulasingam S, Lawrence WF.

J Gen Intern Med. 2012 Jun;27 Suppl 1:S76-82. doi: 10.1007/s11606-012-2019-3.

5.

Contribution of screening and survival differences to racial disparities in colorectal cancer rates.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):728-36. doi: 10.1158/1055-9965.EPI-12-0023. Epub 2012 Apr 18.

7.

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.

8.

Managed care and the diffusion of endoscopy in fee-for-service Medicare.

Mobley LR, Subramanian S, Koschinsky J, Frech HE, Trantham LC, Anselin L.

Health Serv Res. 2011 Dec;46(6pt1):1905-27. doi: 10.1111/j.1475-6773.2011.01301.x. Epub 2011 Aug 16.

9.

Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD.

Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3.

10.

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

Wilschut JA, Steyerberg EW, van Leerdam ME, Lansdorp-Vogelaar I, Habbema JD, van Ballegooijen M.

Cancer. 2011 Sep 15;117(18):4166-74. doi: 10.1002/cncr.26009. Epub 2011 Mar 8.

11.

Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections.

Brenner H, Altenhofen L, Hoffmeister M.

Dtsch Arztebl Int. 2010 Oct;107(43):753-9. doi: 10.3238/arztebl.2010.0753. Epub 2010 Oct 29.

12.

Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, van Ballegooijen M.

Ann Intern Med. 2010 Sep 21;153(6):368-77. doi: 10.7326/0003-4819-153-6-201009210-00004.

13.

Simulation of colorectal cancer screening: what we do and do not know and does it matter.

van Ballegooijen M, Boer R, Zauber AG.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):427-37. doi: 10.1016/j.bpg.2010.07.001.

14.

Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis.

Mobley LR, Kuo TM, Urato M, Subramanian S.

Int J Health Geogr. 2010 Sep 3;9:44. doi: 10.1186/1476-072X-9-44.

15.

Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Ladabaum U, Ferrandez A, Lanas A.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2765-76. doi: 10.1158/1055-9965.EPI-10-0530. Epub 2010 Sep 1.

16.

Hospital costs of colorectal cancer care.

Macafee DA, West J, Scholefield JH, Whynes DK.

Clin Med Oncol. 2009 Mar 20;3:27-37.

17.

Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Ginsberg GM, Lim SS, Lauer JA, Johns BP, Sepulveda CR.

Cost Eff Resour Alloc. 2010 Mar 17;8:2. doi: 10.1186/1478-7547-8-2.

18.

Performance value of high risk factors in colorectal cancer screening in China.

Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ.

World J Gastroenterol. 2009 Dec 28;15(48):6111-6.

19.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

20.

Calibration methods used in cancer simulation models and suggested reporting guidelines.

Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS.

Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000. Review.

Items per page

Supplemental Content

Write to the Help Desk